Walleye Trading’s Standard BioTools LAB Stock Holding History

Walleye Trading’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,700	Closed	-$10K	–	5419
2022 Q1	$10K	Sell	2,700 -28,500	-91%	-$98.4K	﹤0.01%	4946
2021 Q4	$122K	Buy	31,200 +12,900	+70%	+$60.4K	﹤0.01%	4269
2021 Q3	$121K	Buy	+18,300	New	+$120K	﹤0.01%	4259
2016 Q3	–	Sell	-1,900	Closed	-$18K	–	5140
2016 Q2	$18K	Buy	1,900 +500	+36%	+$4.7K	﹤0.01%	4618
2016 Q1	$11K	Buy	1,400 +1,000	+250%	+$7.21K	﹤0.01%	4696
2015 Q4	$4K	Sell	400 -300	-43%	-$2.95K	﹤0.01%	4972
2015 Q3	$6K	Sell	700 -3,400	-83%	-$53.5K	﹤0.01%	4562
2015 Q2	$99K	Buy	4,100 +3,900	+1,950%	+$123K	﹤0.01%	3049
2015 Q1	$8K	Sell	200 -200	-50%	-$7.91K	﹤0.01%	3746
2014 Q4	$13K	Buy	400 +100	+33%	+$2.83K	﹤0.01%	3837
2014 Q3	$7K	Buy	+300	New	+$8.43K	﹤0.01%	3825

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading's LAB Position: Q2 2022 in Review

Walleye Trading sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 13,125 shares — an estimated $47K sold.

Walleye Trading first reported a position in LAB in Q3 2014 and held it in 17 quarters. The position peaked at $385K in Q1 2019. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

Walleye Trading reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
Walleye Trading sold 13,125 Standard BioTools shares in Q2 2022, an estimated $47K.
Walleye Trading first reported a position in Standard BioTools in Q3 2014 and held it in 17 quarters.
Walleye Trading's Standard BioTools position peaked at $385K in Q1 2019.
86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.